Artelo Biosciences to Present at Sequire Biotechnology Conference on February 2nd
CEO Gregory Gorgas to discuss developments related to the Company’s Cancer Appetite Recovery Study (CAReS)
Presentation on Thursday, February 2, 2023 at 1:00 PM ET
Related news for (ARTL)
- Artelo Biosciences Announces $9.475 Million At-the-Market Private Placement to Initiate Solana Treasury Strategy, Becoming First Publicly-Traded Pharmaceutical Company to Adopt SOL as a Core Reserve Asset
- 24/7 Market News Snapshot 04 August, 2025 – Artelo Biosciences, Inc. Common Stock (NASDAQ:ARTL)
- Artelo Biosciences Receives Favorable UK MHRA Guidance for a Phase 1 Trial of ART12.11, the Company’s Proprietary CBD:TMP Cocrystal Being Developed for the Treatment of Anxiety and Depression
- Today’s Top Performers: MoBot’s Market Review 07/07/25 05:00 PM
- Breaking News: MoBot’s Latest Update as of 07/07/25 04:00 PM